Division of Practice Advancement and Clinical Education, University of North Carolina Eshelman School of Pharmacy, 301 Pharmacy Lane, Chapel Hill, NC, 27599, USA.
Division of Practice Advancement and Clinical Education, University of North Carolina Eshelman School of Pharmacy, 301 Pharmacy Lane, Chapel Hill, NC, 27599, USA.
Res Social Adm Pharm. 2020 Oct;16(10):1416-1421. doi: 10.1016/j.sapharm.2020.01.001. Epub 2020 Jan 2.
Comprehensive medication management (CMM) is a patient care process provided by clinical pharmacists in primary care settings that ensures optimal use of medications with timely follow-up. Despite widespread evidence that shows CMM improves clinical and medication-related outcomes, pharmacist-delivered CMM services often fail to be adopted into U.S. primary care settings.
This study presents a conceptual framework linking outcomes of pharmacist-delivered CMM services in primary care settings to financial benefits for health plans providing coverage of CMM services and primary care practices investing and implementing CMM.
A critical review of the literature was performed in PubMed and the gray literature to identify financing opportunities that justify the coverage of CMM by third-party health plan administrators or the implementation of CMM by primary care practices. Financing elements that could be impacted by pharmacist-led CMM outcomes, namely higher achievement of medication-related quality measures and reduction of total costs of care, were recorded and utilized to develop the conceptual framework.
The framework suggests that CMM provides economic benefits to both health plans and primary care practices by increasing market competitiveness, direct revenue, and quality bonuses. Health plans may benefit from higher plan quality ratings, lower premiums and plan bids, increased shared savings, and quality bonus payments. Primary care practices may achieve increased negotiating power through accreditation recognition and patient satisfaction, increased revenue through shared savings and fee-for-service reimbursement, and achievement of quality bonus payments.
The alignment of economic benefits from CMM advances a strong value proposition for greater adoption of CMM coverage by health plans and implementation in the U.S. primary care system. Through broader CMM implementation, pharmacists can work alongside physicians in advanced care models and play a vital role in shaping the primary care practice transition to value-based care.
综合药物管理(CMM)是临床药师在基层医疗环境中提供的一种患者护理流程,可确保药物的最佳使用并及时进行随访。尽管有广泛的证据表明 CMM 可改善临床和药物相关的结果,但药师提供的 CMM 服务往往未能被纳入美国基层医疗环境中。
本研究提出了一个概念框架,将初级保健环境中药师提供的 CMM 服务的结果与为 CMM 服务提供保险覆盖的健康计划和投资并实施 CMM 的初级保健实践的经济利益联系起来。
在 PubMed 和灰色文献中进行了文献综述,以确定可以证明第三方健康计划管理者为 CMM 提供保险或初级保健实践实施 CMM 的经济机会。记录并利用与药师主导的 CMM 结果相关的财务要素,即更高的药物相关质量指标的实现和总护理成本的降低,以开发概念框架。
该框架表明,CMM 通过提高市场竞争力、直接收入和质量奖金,为健康计划和初级保健实践带来经济效益。健康计划可能从更高的计划质量评级、更低的保费和计划竞标、增加的共享储蓄和质量奖金支付中受益。初级保健实践可能通过认可和患者满意度提高谈判能力、通过共享储蓄和按服务收费报销增加收入以及实现质量奖金支付。
从 CMM 中获得的经济利益的一致性为健康计划更广泛地采用 CMM 覆盖范围并在美国家庭医疗系统中实施提供了强有力的价值主张。通过更广泛的 CMM 实施,药剂师可以与医生一起在高级护理模式中工作,并在塑造初级保健实践向基于价值的护理的过渡方面发挥重要作用。